Xcout IntelQuidelOrtho competitors & alternatives
The 12 closest competitors and alternatives to QuidelOrtho among medical devices companies — ranked by similarity to what QuidelOrtho actually does, not by market-cap band.
Subscribe to see QuidelOrtho’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About QuidelOrtho
QuidelOrtho Corporation is dedicated to the creation and manufacturing of diagnostic testing technologies that address the full range of healthcare testing demands. The company operates through distinct business units: Laboratories, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics. The Laboratories segment provides instruments and assays for clinical chemistry, which measure specific chemical markers in bodily fluids to aid in health evaluation and patient management. It also offers immunoassay instruments and tests designed to detect proteins acting as antigens (indicating disease spread), antibodies (reflecting immune response), or markers of organ health and function. Furthermore, this unit develops testing solutions for monitoring disease progression across various therapeutic fields, along with specialized diagnostic tools. The Transfusion Medicine segment supplies immunohematology instruments and tests vital for blood typing, ensuring compatibility between patients and donors during transfusions, as well as donor screening instruments and tests for detecting infectious diseases in blood and plasma. The Point-of-Care business unit focuses on delivering rapid diagnostic tests suitable for diverse immediate care settings. Finally, the Molecular Diagnostics unit offers polymerase chain reaction (PCR) thermocyclers, alongside analyzers and amplification systems. QuidelOrtho distributes its products directly to end-users via its dedicated sales team and through a network of distributors. These offerings are employed professionally in a wide array of environments, including physician practices, hospitals, clinical and reference laboratories, urgent care centers, universities, retail clinics, pharmacies, wellness screening facilities, blood banks, and donor centers. The company's products are also available for individual, non-professional, and over-the-counter use. With operations spanning North America, Europe, the Middle East, Africa, China, and other global regions, QuidelOrtho Corporation was founded in 1979 and maintains its headquarters in San Diego, California.
QuidelOrtho at a glance
QuidelOrtho is a medical devices company headquartered in San Diego, United States. It is publicly listed (0A55) with a market capitalisation of $920.7M. Xcout tracks 29 named people at QuidelOrtho, including Brian J. Blaser (President, Chief Executive Officer & Director).
QuidelOrtho leadership
- Brian J. BlaserPresident, Chief Executive Officer & Director
- Joseph BuskyChief Financial Officer
- Micah YoungChief Financial Officer & Principal Financial Officer
- Jonathan SiegristExecutive Vice President of Research & Development and Chief Technology Officer
- Nathaniel SisitskyChief Legal Officer & Corporate Secretary
- Philip McLellanChief Operations Officer
23 more named people on record for QuidelOrtho, with roles, board committees and tenure — see the full roster →
Top 12 QuidelOrtho competitors
Ranked by semantic similarity — how close each company is to QuidelOrtho by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through two primary divisions: Diagnostics and Molecular Solutions. Its diverse Diagnostics portfolio features a range of crucial offerings, such as the InteliSwab rapid tests for COVID-19 (including professional and prescription versions). It also provides several OraQuick rapid tests, encompassing solutions for HIV (Rapid, In-Home, and Self-Test versions), Hepatitis C (HCV rapid antibody), and Ebola (rapid antigen). Further diagnostic tools include the OraSure oral fluid collection device, utilized for HIV-1 antibody screening and confirmation; the Intercept drug testing systems; various immunoassay tests and reagents; and the Q.E.D. saliva alcohol test. Within its Molecular Solutions segment, OraSure offers an array of genomic products, notably under the Oragene and ORAcollect brand names, alongside specialized microbiome collection solutions and comprehensive GenoFIND genomics laboratory services. The company also supplies collection devices like ORAcollect, RNA, OMNIgene, and RAL, specifically designed for COVID-19 molecular testing. Another key offering is the Colli-Pee device, engineered for the precise volumetric collection of first-void urine. Furthermore, OraSure produces and distributes advanced kits for the collection, stabilization, transportation, and storage of genetic material samples, critical for molecular testing in diverse fields such as academic research, commercial applications (including ancestry, disease risk management, lifestyle analysis), and animal testing. Complementing these, it also provides various other diagnostic tools, including immunoassays and in vitro diagnostic tests. OraSure's sophisticated products and services are distributed to a wide array of clients, including clinical laboratories, hospitals, clinics, various community and public health organizations, wholesale distributors, governmental bodies, medical practices, and a broad spectrum of commercial and industrial entities. Established in 2000, OraSure Technologies, Inc. maintains its corporate headquarters in Bethlehem, Pennsylvania.
Biotechnology and Medical Devices
SD Biosensor is a global diagnostic reagents company that develops and supplies a wide range of diagnostic testing platforms and products, including rapid tests, molecular diagnostics, fluorescence immunoassays, and blood glucose meters. The company serves healthcare providers, laboratories, and patients by offering screening and confirmatory testing solutions for infectious diseases, chronic conditions, and other health markers.
Medical Devices & Diagnostics
Abbott Point of Care provides rapid diagnostic testing solutions and point-of-care medical devices for healthcare professionals.
Similar medical devices company
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Similar medical devices company
EKF Diagnostics Holdings plc, a company founded in 1990 and based in Cardiff, United Kingdom, operates as an international supplier of diagnostic solutions. The firm excels in the development, manufacturing, and distribution of a wide array of diagnostic instruments, chemical reagents, and associated products. Its extensive market reach spans across Europe, the Middle East, the Americas, Asia, Africa, and beyond. The company's product lineup addresses various critical diagnostic needs. This includes a range of hemoglobin analysis devices, such as the handheld DiaSpect Tm and the quantitative Hemo Control. EKF also provides advanced glucose and lactate analyzers like the Biosen C-Line series, alongside point-of-care solutions for diabetes management, exemplified by the Quo-Lab A1c and Quo-Test A1c. Beyond these, their offerings extend to specialized diagnostic tools: the Creamatocrit Plus for assessing lipid concentration in mothers' milk, QuPID and True20 pregnancy tests, and the STAT-Site M Beta-hydroxybutyrate analyzer. EKF further supplies a comprehensive suite of clinical chemical analyzers and reagents, designed for monitoring conditions such as ketosis, glycated albumin, glycated serum protein, and utilizing markers like Procalcitonin for bacterial infections and sepsis. Additional provisions include immunoassay kits, general chemistry analyzers like the Altair 240, micro centrifuges, the Uri-Trak 120 urine analyzer, and dedicated kits and services for COVID-19. The company also offers its manufacturing capabilities as contract solutions to third-party businesses and delivers professional laboratory services.
Similar medical devices company
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Similar medical devices company
HemoCue AB develops and manufactures point-of-care medical diagnostic systems and testing equipment. The company serves healthcare providers in clinical settings, hospitals, blood banks, and public health sectors by offering portable devices for hematology, diabetes management, and infection detection.
Medical Devices, Diagnostics, Life Sciences
Beckman Coulter Diagnostics provides clinical diagnostic products, laboratory automation systems, and testing solutions across disciplines such as chemistry, immunoassay, hematology, and microbiology. The company serves healthcare providers and laboratories by delivering accurate and timely diagnostic insights to inform clinical decisions and improve patient care.
Similar medical devices company
Biofire Group develops syndromic infectious disease diagnostics systems and multiplex PCR testing panels. The company serves clinical laboratories and healthcare providers by delivering rapid detection results for pathogens such as viruses, bacteria, and resistance genes.
Medical - Devices
Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's core offerings include several innovative instruments: The HD-X instrument, which provides highly sensitive and automated multiplex protein detection. The SR-X instrument, enabling researchers to leverage Simoa detection technology for diverse uses, such as the direct detection of nucleic acids. The SP-X instrument, which utilizes Simoa planar array technology for conducting multiplex chemiluminescent immunoassays. Alongside these platforms, Quanterix also supplies crucial consumables, including assay kits and reagents. In addition to its product line, the company delivers various contract research services, encompassing sample analysis, the development of custom "homebrew" assays, and other specialized research and development projects. Quanterix's operational focus spans critical health areas like neurology, oncology, cardiology, infectious diseases, and inflammation. Its clientele within the life science research sector primarily consists of laboratories affiliated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research organizations. Sales are managed through a multifaceted approach, combining a direct sales force, dedicated support organizations, and a network of distributors or sales agents. The company was initially incorporated in 2007 as Digital Genomics, Inc., before rebranding to Quanterix Corporation in August of the same year.
Medical - Devices
Applied BioCode Corporation specializes in the complete lifecycle—from design and development to manufacturing and commercialization—of multiplex diagnostic testing solutions tailored for the In-Vitro Diagnostics (IVD) market. Among its key offerings are two sophisticated systems: the BioCode MDx 3000, an automated molecular diagnostics platform that streamlines PCR amplification, hybridization, and detection steps; and the BioCode 2500 analyzer, specifically engineered to read barcoded magnetic beads (BMBs) and display their unique identification along with fluorescence intensity. The company also boasts an extensive portfolio of diagnostic assays, including the BioCode SARS-CoV-2 Assay, a high-throughput, automated nucleic acid multiplex test for detecting SARS-CoV-2 genetic material in nasopharyngeal swabs. Other panels comprise BioCode Respiratory Pathogen Panels, capable of simultaneously identifying and differentiating seventeen distinct respiratory pathogens in nasopharyngeal samples, and BioCode gastrointestinal (GI) pathogen panels, which target prevalent GI pathogens such as viruses, bacteria, and parasites responsible for infectious diarrheal diseases. An expanding pipeline of MDx assays for various molecular tests is also under development. Beyond these, Applied BioCode provides specialized reagents like analyte-specific reagents for fungal pathogens, and multiplex kits for human cytokines and chemokines, vital for biomarker identification. For research flexibility, they offer premixed and customizable multiplex kits for mouse models, alongside similar cytokine/chemokine multiplex kits for rat, monkey, canine, and non-human primate studies. Rounding out its comprehensive services, the company supplies its proprietary BMBs, calibration beads, and coupling kits for a wide array of bioassay applications. They also offer ELISA (Enzyme-Linked Immunosorbent Assay), a method for the precise quantification of drug, protein, or antibody levels in biological samples such as cell lysates or serum, in addition to providing full-spectrum assay development services. Applied BioCode Corporation is headquartered in Santa Fe Springs, California.
Biotech, Medical Devices
Hangzhou Alltest Biotech Co., Ltd. operates internationally, specializing in the entire process of in vitro diagnostic reagents, from their initial research and development to manufacturing and market distribution. The company supplies a wide array of rapid diagnostic solutions, encompassing crucial health sectors like women's health, infectious disease detection, drug screening, cancer diagnostics, and cardiovascular conditions, among other distinct product series. This enterprise is headquartered in Hangzhou, China.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of QuidelOrtho and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for QuidelOrthoand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →